The Portfolio Committee on Health has concluded provincial public hearings on the Tobacco Products and Electronic Delivery Systems Control Bill (B33-2022) in Geroge, where it received mixed views on ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...